Distribution and antifungal susceptibility of Candida species isolated from different age populations in Taiwan

Medical Mycology

Volumn 44, Issue 3, 2006, Pages 237-242

  Yang, Yun Liang ^a   Cheng, Hsiao Hsu ^b   Lo, Hsiu Jung ^b  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Candida species; Patient age; TSARY; Yeast

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD ANALYSIS; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; FUNGUS ISOLATION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPECIES DISTRIBUTION; SPUTUM ANALYSIS; TAIWAN; URINALYSIS; WOUND INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMPHOTERICIN B; CANDIDA; FLUCONAZOLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI; ISSATCHENKIA ORIENTALIS;

EID: 33646846292     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500401213     Document Type: Article

References (24)

1. Pfaller, MA and Jones, RN and Messer, SA et al. (1998) National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathogens of Epidemiologic Diagn Microbiol Infect Dis, 30, pp. 121-129.
2. Chen, YC and Chang, SC and Sun, CC and (1997) Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993 Infect Control Hosp Epidemiol, 18, pp. 369-375.
3. Cheng, MF and Yu, KW and Tang, RB et al (2004) Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999 Diagn Microbiol Infect Dis, 48, pp. 33-37.
4. Pfaller, MA and Jones, RN and Doern, GV and (2000) Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998 Antimicrob Agents Chemother, 44, pp. 747-751.
5. Yang, YL and Ho, YA and Cheng, HH and (2004) Susceptibilities of Candida species to amphotericin B and fluconazole: The emergence of fluconazole resistance in Candida tropicalis Infect Control Hosp Epidemiol, 25, pp. 60-64.
6. Sanglard, D and Odds, FC. (2002) Resistance of Candida species to antifungal agents: Molecular mechanisms and clinical consequences Lancet Infect Dis, 2, pp. 73-85.
7. Walsh, TJ and Groll, A and Hiemenz, J and (2004) Infections due to emerging and uncommon medically important fungal pathogens Clin Microbiol Infect, 10(Suppl. 1), pp. 48-66.
8. Hadfield, TL and Smith, MB and Winn, RE and (1987) Mycoses caused by Candida lusitaniae Rev Infect Dis, 9, pp. 1006-1012.
9. Orozco, AS and Higginbotham, LM and Hitchcock, CA and (1998) Mechanism of fluconazole resistance in Candida krusei Antimicrob Agents Chemother, 42, pp. 2645-2649.
10. Voss, A and Hollis, RJ and Pfaller, MA and (1994) Investigation of the sequence of colonization and candidemia in nonneutropenic patients J Clin Microbiol, 32, pp. 975-980.
11. Cheng, MF and Yang, YL and Yao, TJ and (2005) Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species BMC Infect Dis, 5, pp. 22.
12. Peman, J and Canton, E and Gobernado, M. (2005) Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain Eur J Clin Microbiol Infect Dis, 24, pp. 23-30.
13. Yang, YL and Li, SY and Cheng, HH and Lo, HJ. (2005) Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002 Diagn Microbiol Infect Dis, 51, pp. 179-183.
14. Lo, HJ and Ho, AH and Ho, M. (2001) Factors accounting for mis-identification of Candida species J Microbiol Immunol Infect, 34, pp. 171-177.
15. Sullivan, D and Coleman, D. (1998) Candida dubliniensis: Characteristics and identification J Clin Microbiol, 36, pp. 329-334.
16. Clinical and Laboratory Standards Institute (formerly NCCLS). Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. M27A 1997.
17. Pfaller, MA and Messer, SA and Hollis, RJ and (1999) Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States Diagn Microbiol Infect Dis, 33, pp. 217-222.
18. Edwards, EJJ.(1990) Candida species. In Principles and Practice of Infectious Diseases. (pp. 1943-1958). New York: Churchill Livingstone.
19. Krcmery, V and Barnes, AJ. (2002) Non-albicans Candida spp. causing fungaemia: Pathogenicity and antifungal resistance J Hosp Infect, 50, pp. 243-260.
20. Voss, A and Kluytmans, JA and Koeleman, JG and (1996) Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals Eur J Clin Microbiol Infect Dis, 15, pp. 909-912.
21. Abi-Said, D and Anaissie, E and Uzun, O and (1997) The epidemiology of hematogenous candidiasis caused by different Candida species Clin Infect Dis, 24, pp. 1122-1128.
22. Levin, AS and Costa, SF and Mussi, NS and (1998) Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers Diagn Microbiol Infect Dis, 30, pp. 243-249.
23. Hedderwick, SA and Lyons, MJ and Liu, M and (2000) Epidemiology of yeast colonization in the intensive care unit Eur J Clin Microbiol Infect Dis, 19, pp. 663-670.
24. Viudes, A and Peman, J and Canton, E and (2002) Candidemia at a tertiary-care hospital: Epidemiology, treatment, clinical outcome and risk factors for death Eur J Clin Microbiol Infect Dis, 21, pp. 767-774.